The Collaborating Centre, based at Utrecht University, Netherlands, was recently awarded the contract following a global competitive bidding process. The objectives of the project are to undertake a series of 10 systematic reviews for updating the evidence-informed WHO guidelines on country pharmaceutical pricing policies
Following an open request for proposals, the Collaborating Centre in association with York Health Economics Consortium (YHEC) submitted a bid to undertake a series of 10 systematic literature reviews (SLRs), in support of the ongoing update of the WHO Pharmaceutical Policy Guideline. As of July 2019, the Collaborating Centre is very happy to announce that WHO has selected our proposal for implementation. The topics of the 10 SLRs, which will be undertaken concurrently towards the end of 2019, are; reference pricing (internal and external), value-based pricing, cost-plus price pricing, setting a price threshold, publishing prices (for transparency), pooled procurement, price discounts for single source pharmaceuticals, promoting the use of quality assured generic medicines, pricing based on tendering and negotiation and tax exemptions or tax reductions for pharmaceuticals.
Team members from the Collaborating Centre contributing expert knowledge on pharmaceutical pricing policies are Aukje Mantel-Teeuwisse (Principal Investigator), post-doc Rianne van den Ham (Project Lead) and professional PhD candidate David Tordrup (Project Lead and project manager). The work will be carried out with the support of colleagues from York Health Economics Consortium who collectively bring substantial expertise in the fields of information science and systematic reviews: Julie Glanville (Associate Director), Chris Bartlett (Senior Research Consultant) and Mick Arber (Senior Information Scientist). The project will be further supported by alumna of the professional PhD programme Dr. Christine Leopold (Project Lead) and independent consultant in the field of access to medicines Rachelle Harris (Project Lead). An internal expert review committee consisting of internationally acclaimed experts in pharmaceutical policy Zaheer-Ud-Din Babar (University of Huddersfield, England), Kalipso Chalkidou (Center for Global Development, London) and Jaime Espin (Andalusian School of Public Health, Spain) will contribute their wealth of knowledge to help ensure the work is carried out to the highest standard.
The Collaborating Centre is very much looking forward to this exciting task to be carried out in collaboration with an excellent research team from both within and outside the Centre.